Human papillomavirus (HPV) is a common sexually transmitted infection spread through intimate skin-to-skin contact. Recommendations for the prevention of HPV have been updated since the initial HPV vaccine was first licensed in the US in 2006. Although immunization is routinely recommended in early adolescence, it is now also available for adults age 27-45 years, and certain patients may benefit from receiving it. However, there are limited resources available to help discuss HPV vaccination with adult patients.
This activity is based on the latest Centers for Disease Control and Prevention (CDC) recommendations for vaccinating US adults against HPV and includes practical implementation strategies for shared clinical decision-making.
Note that by accessing the activity, you will be directed to the online activity hosted by ReachMD
Accreditation and Credit Designation Statement:
The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NFID designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date:
Expiration Date:
This activity is supported by an unrestricted educational grant from Merck & Co., Inc. NFID policies restrict funders from controlling program content.
Related Resources
5 Key Steps to Improve HPV Vaccination Rates
Infographic for healthcare professionals to use as a quick-reference guide that highlights steps to improve HPV vaccination rates
HPV Vaccination as a Public Health Priority
NFID Call to Action on the importance of HPV vaccination (August 2014)